TRVI
Trevi Therapeutics, Inc. · Healthcare
10% owner Ali Behbahani bought $6.8M of Trevi Therapeutics, Inc.
Bought$6,802,999
$1.90Price
3,580,526Shares
+46%Stake
What TRVI did for a copier
- $1,000 copied at Thu, Apr 14 open, $2.92
- $818
- S&P 500, same days
- −6.4%
Measured over 30 trading days, to the May 27 close.
Ali Behbahani's record
4 other buys with 3 months of prices since 2018: on average −19.1% against the S&P 500, and 1 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Apr 11. Filed Wed, Apr 13, 5:10 PM ET, after the close. Returns use the Apr 14 open and the May 27 close. Not investment advice.